USANA amends Bank of America-led USD 75 million revolving credit facility, adds minimum consolidated EBITDA covenant

PUBT · 2d ago
USANA amends Bank of America-led USD 75 million revolving credit facility, adds minimum consolidated EBITDA covenant
  • USANA Health Sciences entered a first amendment on Sept. 30, 2026 to its June 27, 2025 revolving credit agreement.
  • Facility size stays at $75 million, with an accordion option above $200 million; maturity remains June 27, 2030.
  • New covenant requires at least $100 million trailing four-quarter consolidated EBITDA from the quarter ended Oct. 3, 2026.
  • Minimum EBITDA drops to $70 million if aggregate revolving exposure is $50 million or less at period-end.
  • Amendment permits a Sydney property sale by USANA Australia, loosens asset-sale basket to $2.5 million, keeps sale-leasebacks largely restricted.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000896264-26-000060), on October 05, 2026, and is solely responsible for the information contained therein.